Valeant Pharmaceuticals to Hold Conference Call to Announce 2011 Financial
Guidance

News provided by

Valeant Pharmaceuticals International, Inc.

Dec 21, 2010, 08:02 ET

    



    
</pre>
<p>MISSISSAUGA, Ontario, <span class="xn-chron">Dec. 21, 2010</span> /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on <span class="xn-chron">Thursday, January 6, 2011</span> at <span class="xn-chron">10:00 a.m. EST</span> (<span class="xn-chron">7:00 a.m. PST</span>) to announce 2011 financial guidance.</p>
<p/>
<p>The dial-in number to participate on this call is (877) 295-5743, confirmation code 33773161.  International callers should dial (973) 200-3961, confirmation code 33773161. A replay will be available approximately two hours following the conclusion of the conference call to <span class="xn-chron">Thursday, January 13, 2011</span>, and can be accessed by dialing (800) 642-1687 or (706) 645-9291, confirmation code 33773161.</p>
<p/>
<p>The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at <a href="http://www.valeant.com">www.valeant.com</a>. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at <a href="http://www.valeant.com">www.valeant.com</a>.</p>
<pre>
    

    About Valeant
    
</pre>
<p>Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at <a href="http://www.valeant.com">www.valeant.com</a>.</p>
<pre>
    


    
</pre>
<p> </p>
<p> </p>
<pre>
    
    Contact Information:
    Laurie W. Little
    949-461-6002
    [email protected]



    (Logo: <a href="http://photos.prnewswire.com/prnh/20101025/LA87217LOGO">http://photos.prnewswire.com/prnh/20101025/LA87217LOGO</a>)

For further information: For further information: Laurie W. Little of Valeant Pharmaceuticals International, Inc., +1-949-461-6002, [email protected] Web Site: http://www.valeant.com

Organization Profile

Valeant Pharmaceuticals International, Inc.